Replimune Group Statistics
NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
19.07-0.16 (-0.83%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Replimune Group by the numbers
Replimune Group has a market capitalization of $1.81 billion based on 94.80M shares outstanding. With trailing EPS of $-2.79, Replimune Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.3% above its 50-day average and 84.9% above its 200-day average.
Average daily trading volume is 2.48M shares, or about $47.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
REPL valuation vs. peer median
| Metric | REPL | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.81B | $1.72B | +5% |
| Avg. volume | 2.48M | 1.59M | +56% |
Peer median across 8 companies: COAG, BCRX, LYCA, MAZE, VIR, RXRX, BEAM, ALVO.
Valuation
- Market cap
- $1.81B
- EPS (TTM)
- $-2.79
- Shares outstanding
- 94.80M
Price and trading
- Previous close
- 19.23
- Open
- 18.80
- Day range
- 18.70 – 19.50
- 52-week range
- 1.50 – 23.54
- 52-week change
- +107.28%
- Beta
- —
- Volume
- 1.96M
- Average volume
- 2.48M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 1.81B
- Forward Pe
- -28.43
- Eps
- -2.79
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.54
- Week52 Low
- 1.50
- Avg Volume
- 2.48M
- Shares Outstanding
- 94.80M
- Ma50
- 15.34
- Ma200
- 10.31
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -18.99%
- Pct From52w Low
- 1171.33%